HLTH Europe 2026, held in Amsterdam, brought together a diverse ecosystem of over 5,000 stakeholders across providers, payers, health systems, technology vendors, startups, investors, and policymakers, serving as a key indicator of the evolving European digital health landscape. Discussions consistently reinforced that healthcare AI is entering a new phase of maturity, shifting from proof-of-concept initiatives to scalable implementation focused on governance, interoperability, workflow integration, and demonstrable return on investment.

Healthcare AI is transitioning from isolated pilot initiatives to enterprise-wide deployment. Discussions across health systems, technology vendors, and policymakers consistently highlighted that organizations are moving beyond evaluating AI capabilities toward embedding AI within clinical, administrative, and operational workflows. As workforce shortages, administrative burden, and financial pressures continue to intensify, healthcare organizations are prioritizing technologies that improve workflow efficiency while delivering measurable clinical and operational outcomes.

Conversations throughout HLTH Europe highlighted growing concerns around data privacy, clinical accountability, regulatory compliance, and the increasing use of ungoverned or "shadow AI" tools. Providers, policymakers, and health systems emphasized that scaling AI requires more than technological capability. It demands robust governance frameworks that ensure transparency, patient safety, explainability, and appropriate human oversight.

• Why is governance emerging as one of the industry's most critical success factors?
• How can you uncover new growth avenues and harness the rapidly accelerating adoption of AI across healthcare?
• Which growth drivers are emerging due to the transition of healthcare AI from isolated pilot initiatives to enterprise-wide deployment?